CME Activity Expired, To Be Used as an Educational Resource Only

Jointly sponsored by Curatio CME Institute LLC and the Multiple Myeloma Research Foundation

Support for this activity has been made possible through an unrestricted educational grant from Celgene Corporation.

Curatio CME Institute LLC and the MMRF present this CME Internet activity on current issues relating to thalidomide-based therapy for patients with multiple myeloma. This program offers physicians the opportunity to learn from experts in this field from the convenience of their home or office. The program consists of two 20-minute presentations and answers to frequently asked questions.

Current Status and New Therapeutics for the Treatment of Patients With Newly Diagnosed or Relapsed/Refractory Multiple Myeloma
Nikhil C. Munshi, MD (bio)
Associate Director
Jerome Lipper Multiple Myeloma Center
Dana-Farber Cancer Institute
Harvard Medical School
Boston, Massachusetts

Practical Issues With Thalidomide-Based Therapy
S. Vincent Rajkumar, MD (bio)
Associate Professor of Medicine
Mayo Clinic College of Medicine
Rochester, Minnesota

Release date: March 28, 2005
Expiration date: March 28, 2006
Estimated time to complete the educational activity: 1 hour